Chikungunya virus nsP3 & nsP4 interacts with HSP-90 to promote virus replication: HSP-90 inhibitors reduce CHIKV infection and inflammation in vivo

by Rathore, A.P.S., Haystead, T., Das, P.K., Merits, A., Ng, M.-L., Vasudevan, S.G.
Published 2014

VCP/p97 is a proviral host factor for replication of chikungunya virus and other alphaviruses

by Carissimo, G., Chan, Y.-H., Utt, A., Chua, T.-K., Bakar, F.A., Merits, A., Ng, L.F.P.
Published 2022

Antiviral activity of silymarin against chikungunya virus

by Lani, R, Hassandarvish, P, Chiam, CW, Moghaddam, E, CHU JANG HANN, Rausalu, K, Merits, A, Higgs, S, Vanlandingham, D, Abu Bakar, S, Zandi, K
Published 2020

Unique epitopes recognized by antibodies induced in chikungunya virus-infected non-human primates: Implications for the study of immunopathology and vaccine development

by Kam Y.-W., Lee W.W.L., Simarmata D., Le Grand R., Tolou H., Merits A., Roques P., Ng L.F.P.
Published 2020

Mutating chikungunya virus non-structural protein produces potent live-attenuated vaccine candidate

by Chan, Y.-H., Teo, T.-H., Utt, A., Tan, J.J.L., Amrun, S.N., Abu Bakar, F., Yee, W.-X., Becht, E., Lee, C.Y.-P., Lee, B., Rajarethinam, R., Newell, E., Merits, A., Carissimo, G., Lum, F.-M., Ng, L.F.P.
Published 2021

Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response

by Her, Z, Teng, T.-S, Tan, J.J.L, Teo, T.-H, Kam, Y.-W, Lum, F.-M, Lee, W.W.L, Gabriel, C, Melchiotti, R, Andiappan, A.K, Lulla, V, Lulla, A, Win, M.K, Chow, A, Biswas, S.K, Leo, Y.-S, Lecuit, M, Merits, A, Rénia, L, Ng, L.F.P
Published 2020